There is growing evidence that Claudin 4 (CLDN4) plays a significant role in the occurrence and development of chromophobe renal cell carcinoma and could serve as an independent risk biomarker for the overall survival in patients with chromophobe renal cell carcinoma [17]. This evidence concerns the gene CLDN4 and chromophobe renal cell carcinoma.